12th Western Pacific Congress on
Chemotherapy and Infectious Diseases
2nd - 5th December 2010, Singapore
Chemotherapy and Infectious Diseases
2nd - 5th December 2010, Singapore
- Committees
- Collaborating
Organizations - Provisional
Scientific Program- CS1: Dengue Virus
- CS2: Infection Control
- CS3: Paediatric Symposium I
- CS4: MRSA
- CS5: Epidemic Preparedness
- CS6: Vaccines for Adults
- CS7: ID and Catastrophes
- CS8: A Primer for Trainees
- CS9: Carbapenem Resistance and Beyond
- CS10: Fungal Infections in ICH
- CS11: Mosquito-borne Diseases
- CS12: UTI
- CS14: Emerging Infections
- CS15: Paediatric Symposium II
- CS17: MDR-acinetobacter
- CS18: New Antimicrobials and Beyond
- CS20: Influenza
- CS21: Management of Infections in Intensive Care
- CS22: Reducing Antibiotic Use in Hospitals
- CS23: CMV
- CS24: Melioidosis
- CS25: Tuberculosis
- CS26: Food Safety
- CS27: Antimicrobial Resistance Surveillance in Asia
- Confirmed Speakers
- 7th Singapore
AIDS Conference - WPSC Young
Investigator Award - Accommodation
- Optional Tours
- About Singapore
- Sponsorship &
Exhibition
Congress Symposium 4:
MRSA
| 4.1 | Molecular Evolution of MRSA | Keiichi HIRAMATSU, Japan |
| 4.2 | Pre-operative MRSA-colonised Patients: Vancomycin Prophylaxis or Decolonisation | Dennis MAKI, USA |
| 4.3 | Is Vancomycin Redundant? | Ian M. GOULD, UK |
| 4.4 | Alternatives to Vancomycin: Which is Best? | John TURNIDGE, Australia |